Quince Therapeutics has rebranded as IRulya Therapeutics, shifting focus to the clinical development of LAM-001, an inhaled rapamycin formulation targeting serious pulmonary diseases like PH-ILD, BOS, and SAPH. The company completed a merger with Orphai Therapeutics and raised $115 million in May 2026, boosting its cash reserves to $116 million to fund operations through 2028. IRulya is advancing multiple Phase 2 clinical trials with anticipated data readouts between 2027 and 2028. Leadership changes include a new CEO, CFO, and COO, alongside a strengthened board to support its strategic direction.
IRulya Therapeutics' relaunch is noted here with Pluang's health sector data for context. As of Oct 09, 2026 18:51 WIB, 71 of 128 health-sector US stocks rose while 49 fell. Notable movers include Centene Corp at USD 65.76 with a 1.89% increase and Twist Bioscience Corp at USD 154.45 with a 1.58% rise, while Aurora Cannabis Inc declined 2.03% to USD 4.34 with 100% sell order activity on Pluang.
At Malaysia's IGEM 2026, Sigenergy showcased its latest AI-driven energy technologies, including smart storage and inverter systems, highlighting its role in advancing sustainable energy. The company also signed MOUs with local partners Milieu and YT...
A vote on Cardano proposes reducing the fixed minimum stake pool fee from 170 ADA to 75 ADA to help small pools remain viable amid declining block rewards. As of October 10, 2026, approval stands at 34.45% against a required 67%, with the vote closin...
Worldcoin (WLD) surged 9.32% in just four hours to $0.5701 on October 10, extending its 24-hour gain to 14.73%. The price rose from $0.5215 earlier that day, reflecting strong buying interest. During the same period, liquidations related to WLD total...
Bitcoin faces pressure as long-term U.S. Treasury yields hit two-decade highs, rising above 5.3% for 10-year and 5.7% for 30-year bonds. This increase makes government bonds more attractive compared to non-yielding assets like Bitcoin, especially as ...
NEAR Protocol traded at $4.93 on October 10, 2026, rising 8.6% after a sharp 16.37% drop the day before. Despite a 97.5% gain over 30 days, the price has been volatile and flat over the past two weeks, fluctuating within a narrow range. This volatili...
